| Similar Articles |
|---|
 |
Pharmaceutical Executive
June 1, 2011 |
Filling in the Bigger Picture Part II of The Avoca Group's 2011 CRO survey on clinical development outsourcing relationships.   |
Pharmaceutical Executive
March 1, 2011 |
Clinical Development Outsourcing: Are We Having Fun Yet? A sneak preview of The Avoca Group's 2011 Annual Survey on CRO and Industry Relationships. |
Bio-IT World
April 16, 2004
Joel Hoffman |
Taking the Trial Out of Clinical Outsourcing Make sure the vendor's standard operating procedures will mesh with your own, and then tirelessly work toward systems integration. |
Pharmaceutical Executive
February 1, 2011
Stergiopoulos et al. |
Honing Reforms from Clinical Development Increased efficiency and lower operating costs for both CROs and vendors can be achieved by eliminating activities |
Pharmaceutical Executive
January 1, 2011
Singh & Glozman |
Managing Clinical Trials in Emerging Markets Amgen's hub-and-spoke system combines control at home with the flexibility to respond to local needs. |
The Motley Fool
March 6, 2009
Brian Orelli |
For Drug Companies, R&D Is Spelled C-R-O It seems likely that more and more pharma companies will try to get more bang for their bucks by spending them on research and development done outside the company, outsourcing it to clinical research organizations. |
The Motley Fool
April 20, 2011
Brandon Glenn |
Growing CRO Demand Boosts Outlook for Kendle It's been rough going lately for Kendle. |
The Motley Fool
January 13, 2011
Brian Orelli |
This Trendy Pharma Is Making a Stylish Move Merck signs up a CRO to help with biosimilars. |
The Motley Fool
July 30, 2009
Robert Steyer |
Covance Advances Covance latest results produce more optimism than did some of its contract research peers. |
Pharmaceutical Executive
July 1, 2012
William Looney |
Today's Mission Critical: Making Sense of Spending on Clinical Trials Mastery of the clinical trial process has become essential to positioning new therapies for leadership in an increasingly crowded and lengthy race to registration. |
Pharmaceutical Executive
December 1, 2012
Torrey et al. |
Transforming Drug Development: A Case Study Eli Lilly's pioneering pact with leading CRO Covance made big news when it happened. Four years later, both parties can point to metrics that suggest the benefit is mutual. |
The Motley Fool
November 30, 2007
Brian Orelli |
Clinical Trial Failures Don't Bother These Companies Contract research organizations, outsourcing companies hired by pharmaceutical and biotech companies to run pre-clinical tests and clinical trials for them, succeed even when drugs fail, and more work may be coming their way. |
CIO
November 1, 2000
Tracy Mayor |
Our Vendors, Ourselves - Interview: Frank Casale Frank Casale wants you to love your outsourcer as yourself... |
The Motley Fool
July 22, 2009
Robert Steyer |
Canaries in the Drug Coal Mine Contract research organizations like Pharmaceutical Product Development and ICON reflect an ailing drug industry. |
Bio-IT World
August 2005
Ellen H. Julian |
Tech Expertise Singles Out Outsourcers Biopharmaceutical companies are flocking to consultants, outsourcers, and staffing firms to help with discrete clinical trial processes to gain access to advanced technologies and reduce the drain on already-scarce IT resources. |
The Motley Fool
August 1, 2008
Brian Orelli |
Recession Schmession, This Industry Is On Fire Contract research organizations do pre-clinical research and run clinical trials for drug developers on the cheap. With pharmaceutical companies cutting back on costs, CROs are in the perfect position to benefit. |
The Motley Fool
August 25, 2006
Brian Gorman |
California's Drug Demands As the pressure grows on drugmakers from legislation, growth and consolidation in the outsourcing business seem likely. |
Bio-IT World
January 13, 2003
Mark D. Uehling |
Powerhouse CRO (Slowly) Goes Electronic Unhappy customers at Quintiles -- the world's largest CRO (contract research organization) -- are rare. It kept plugging away at the startup process, redesigning it from scratch. Now starting electronic trials takes no longer than paper ones. |
Pharmaceutical Executive
October 1, 2010 |
Knowledge-Based Outsourcing: Driving Deeper Insights Outsourcing is fairly commonplace in the world of pharma. Tracking, monitoring, and trend evaluation is not enough. Companies must now do more than assess what happened and why. |
Pharmaceutical Executive
November 1, 2006 |
Unraveling the eSource Industry-wide standards for electronic patient data have long felt like buried treasure. Companies today are getting closer - by way of a tangled map. |
Wall Street & Technology
June 13, 2006 |
Spending More Can Be Satisfying Research from an outsourcing and insourcing advisory firm reveals a direct correlation between an organization's satisfaction with its outsourcing efforts and how much it invests in outsourcing management and governance. |
The Motley Fool
June 15, 2006
Brian Gorman |
Covance Gets Strategic The drug research service company's latest deal could help it cement its leadership in the industry. Investors, take note. |
The Motley Fool
April 24, 2009
Robert Steyer |
Nothing to CRO About The good times have stopped rolling for Contract research organizations, as they warn of unexpected contract cancellations and reduced demand for services. |
Pharmaceutical Executive
June 1, 2007
Dinh Nguyen |
Clinical Trials Under Scrutiny Over the last few years, there has been a growing number of instances of misconduct in clinical research. |
Global Services
March 6, 2008 |
Enabling Better Business & IT Alignment What will set apart great business leaders is the ability to adapt to and manage change well. Here are some tips for selecting and managing multiple IT service providers |
Bio-IT World
March 17, 2004
Kenneth Getz |
Getting Past No Low adoption rates of e-clinical trial technology can't be blamed on external market dynamics alone. Biopharmas must face four inhibitors within their own organizations |
Pharmaceutical Executive
June 1, 2013 |
When Gurus Get It Wrong Despite their high status, management gurus aren't always on point when it comes to pharma, writes John Ansell. |
The Motley Fool
August 27, 2011
Michael Olsen |
Rising Star Buy: More Icon Icon shares might not appreciate tomorrow, and they might decline more before they go up. But here is a rare value: a secular growth story at a stellar valuation. |
Bio-IT World
January 21, 2005
Sprouse & Shiple |
Strategic Insights: Building Integrated Research Networks Uniting a region's medical centers on clinical projects could create a new model for clinical trials. |
Bank Systems & Technology
June 2, 2004
Cynthia Ramsaran |
Scotiabank Starts With the Basics Though outsourcing overseas raises data security concerns, banks that outsource onshore face many of the the same issues. A discussion with Scotiabank Group's vice president of strategic sourcing about how the bank approaches outsourcing. |
Global Services
August 14, 2008
Phil Fersht |
Dodging the Outsourcing Landmines With growing reliance on their providers to deliver, greater scrutiny by boards and their auditors, and such, driving change deep into firms, execs governing outsourcing relationships have become a lightning rod for criticism. |
Pharmaceutical Executive
October 1, 2008
RS Kumar |
Evolving Clinical Trials Clinical trials need to change. A recent survey shows that industry should address the research supply chain for the greatest gains in efficiency. |
FAO Today
Mar/Apr 2008
Phil Fersht |
Judgment Calls The worst mistakes companies make when they evaluate outsourcing -- and how to avoid them. |
The Motley Fool
October 23, 2009
Robert Steyer |
Taking the Drug Industry's Temperature Covance and Icon hint at broader pharmaceutical R&D trends. |
Bio-IT World
May 9, 2003
Mark D. Uehling |
Data Rapture? Electronic capture of data: Some say it unclogs the medieval clinical trials process. Others remain skeptical of software and put their trust in paper. |
Insurance & Technology
May 16, 2007
Peggy Bresnick Kendler |
Effective Vendor Management Enables Insurance Companies to Get the Most Out of Software, IT Services and Outsourcing Contracts Questions and answers about insurer/vendor relationships. |
The Motley Fool
July 27, 2011
Michael Olsen |
Rising Stars Buy: Icon Icon, the fourth-largest CRO, sits among the global elite and makes for a healthy investment. |
HBS Working Knowledge
July 4, 2005
Poping Lin |
Should You Outsource Your Marketing? Most companies already outsource a portion of their marketing function -- advertising. But what about direct-mail management, lead management, or customer analytics? |
The Motley Fool
December 27, 2007
Brian Orelli |
Drugmaker Growth: The China Connection Just like other industries, the pharmaceutical industry has realized that China is a good place to find cheap labor. While reluctant to set up FDA-regulated manufacturing plants in China, other stages of drug development can be done there. |
CIO
October 1, 2005
Stephanie Overby |
Simple Successful Outsourcing CIOs who outsource discrete processes that have well-defined business rules are almost always happy with the outcome. |
The Motley Fool
December 8, 2004
Alyce Lomax |
Eli Lilly Bares All The pharmaceutical publishes clinical trial results online. This is a step toward generating trust -- after all, shareholders, physicians, and consumers alike are likely looking askew at Big Pharma these days. |
Global Services
October 31, 2008
Mike Beals |
Governance Tools Can be a Game Changer A successful outsourcing initiative requires the implementation of a disciplined outsourcing lifecycle methodology. To make this methodology work, both the customer and the service provider must together design an approach to govern the relationship using the right governance tools and guidelines |
Pharmaceutical Executive
September 1, 2010 |
Explaining the Drug Drought Industry needs to engage in a broader public debate on ways to rekindle the innovative engine in new drug discovery and development. |
Bio-IT World
May 2006
Mark D. Uehling |
Bio-IT World CTMS Survey An online survey of the clinical trial management system market reveals some divergences between how the pharma/biotech folks and the contract research folks see the CTMS landscape. Are our respondents happy with the CTMS landscape? |
Food Engineering
April 1, 2008 |
Outsourcing requires homework There's no doubt that outsourcing can save money and take the pressure off several business tasks -- if executed properly. But many companies don't do homework first, according to this Deloitte Consulting 2008 report. |
Bio-IT World
April 15, 2003
Paul Bleicher |
E-Sourcing: Covering the Regulatory Bases Capturing clinical source data electronically can hit a home run for trial efficiency and safety -- but access control is key. Here's an expert guide. |
Pharmaceutical Executive
July 1, 2005
Ellen H. Julian |
What Pharma Wants From IT Today Indications that compliance and productivity issues reign over information technology (IT) budgets at pharma companies were verified in the 2005 Pharmaceutical Executive/Life Science Insights Information Technology Survey of nearly 850 US pharma companies. |
Bank Systems & Technology
May 7, 2007
Peggy Bresnick Kendler |
Bank Tech Experts Discuss Vendor Relationships Here, these industry experts talk about outsourcing and offshoring along with other areas of bank tech concerns. |
FAO Today
Mar/Apr 2008
Lisa Ross |
Department Procurement: Try Adding Procurement By outsourcing finance & accounting and procurement together, you can fan the flames of powerful synergies that will go straight to the bottom line -- while helping to improve operations. |
FAO Today
Nov/Dec 2007
Bob Cecil |
Deals for the Next Decade of Finance and Accounting Outsourcing Increased buyer savvy paves the way for notable shifts in deal structure. |
